Literature DB >> 33418506

HPV16 E6 seropositivity and oropharyngeal cancer: Marker of exposure, risk, or disease?

Rebecca Landy1, Anil K Chaturvedi2.   

Abstract

Entities:  

Year:  2021        PMID： 33418506      PMCID： PMC7804595          DOI： 10.1016/j.ebiom.2020.103190

Source DB:  PubMed          Journal:  EBioMedicine        ISSN： 2352-3964            Impact factor:   8.143


× No keyword cloud information.
  10 in total

1.  Prevalence of oral HPV infection in the United States, 2009-2010.

Authors:  Maura L Gillison; Tatevik Broutian; Robert K L Pickard; Zhen-you Tong; Weihong Xiao; Lisa Kahle; Barry I Graubard; Anil K Chaturvedi
Journal:  JAMA       Date:  2012-01-26       Impact factor: 56.272

Review 2.  Epidemiology of Human Papillomavirus-Positive Head and Neck Squamous Cell Carcinoma.

Authors:  Maura L Gillison; Anil K Chaturvedi; William F Anderson; Carole Fakhry
Journal:  J Clin Oncol       Date:  2015-09-08       Impact factor: 44.544

3.  Incidence and clearance of oral human papillomavirus infection in men: the HIM cohort study.

Authors:  Aimée R Kreimer; Christine M Pierce Campbell; Hui-Yi Lin; William Fulp; Mary R Papenfuss; Martha Abrahamsen; Allan Hildesheim; Luisa L Villa; Jorge J Salmerón; Eduardo Lazcano-Ponce; Anna R Giuliano
Journal:  Lancet       Date:  2013-07-02       Impact factor: 79.321

4.  Kinetics of the Human Papillomavirus Type 16 E6 Antibody Response Prior to Oropharyngeal Cancer.

Authors:  Aimée R Kreimer; Mattias Johansson; Elizabeth L Yanik; Hormuzd A Katki; David P Check; Krystle A Lang Kuhs; Martina Willhauck-Fleckenstein; Dana Holzinger; Allan Hildesheim; Ruth Pfeiffer; Craig Williams; Neal D Freedman; Wen-Yi Huang; Mark P Purdue; Angelika Michel; Michael Pawlita; Paul Brennan; Tim Waterboer
Journal:  J Natl Cancer Inst       Date:  2017-08-01       Impact factor: 13.506

Review 5.  Molecular pathology of head and neck cancer: implications for diagnosis, prognosis, and treatment.

Authors:  Sara I Pai; William H Westra
Journal:  Annu Rev Pathol       Date:  2009       Impact factor: 23.472

Review 6.  Carcinogenic human papillomavirus infection.

Authors:  Mark Schiffman; John Doorbar; Nicolas Wentzensen; Silvia de Sanjosé; Carole Fakhry; Bradley J Monk; Margaret A Stanley; Silvia Franceschi
Journal:  Nat Rev Dis Primers       Date:  2016-12-01       Impact factor: 52.329

7.  Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study.

Authors:  Aimée R Kreimer; Paul Brennan; Krystle A Lang Kuhs; Tim Waterboer; Gary Clifford; Silvia Franceschi; Angelika Michel; Martina Willhauck-Fleckenstein; Elio Riboli; Xavier Castellsagué; Allan Hildesheim; Renée Turzanski Fortner; Rudolf Kaaks; Domenico Palli; Ingrid Ljuslinder; Salvatore Panico; Françoise Clavel-Chapelon; Marie-Christine Boutron-Ruault; Sylvie Mesrine; Antonia Trichopoulou; Pagona Lagiou; Dimitrios Trichopoulos; Petra H Peeters; Amanda J Cross; H Bas Bueno-de-Mesquita; Paolo Vineis; Nerea Larrañaga; Valeria Pala; María-José Sánchez; Carmen Navarro; Aurelio Barricarte; Rosario Tumino; Kay-Tee Khaw; Nicholas Wareham; Heiner Boeing; Annika Steffen; Ruth C Travis; J Ramón Quirós; Elisabete Weiderpass; Michael Pawlita; Mattias Johansson
Journal:  J Clin Oncol       Date:  2015-02-09       Impact factor: 44.544

8.  Timing of HPV16-E6 antibody seroconversion before OPSCC: findings from the HPVC3 consortium.

Authors:  A R Kreimer; A Ferreiro-Iglesias; M Nygard; N Bender; L Schroeder; A Hildesheim; H A Robbins; M Pawlita; H Langseth; N F Schlecht; L F Tinker; I Agalliu; S W Smoller; E Ness-Jensen; K Hveem; G D'Souza; K Visvanathan; B May; G Ursin; E Weiderpass; G G Giles; R L Milne; Q Cai; W J Blot; W Zheng; S J Weinstein; D Albanes; N Brenner; J Hoffman-Bolton; R Kaaks; A Barricarte; A Tjønneland; C Sacerdote; A Trichopoulou; R C H Vermeulen; W-Y Huang; N D Freedman; P Brennan; T Waterboer; M Johansson
Journal:  Ann Oncol       Date:  2019-08-01       Impact factor: 32.976

9.  Long-term Persistence of Oral HPV Over 7 Years of Follow-up.

Authors:  Gypsyamber D'Souza; Gwendolyn Clemens; Howard D Strickler; Dorothy J Wiley; Tanya Troy; Linda Struijk; Maura Gillison; Carole Fakhry
Journal:  JNCI Cancer Spectr       Date:  2020-06-05

10.  Characterization of human papillomavirus (HPV) 16 E6 seropositive individuals without HPV-associated malignancies after 10 years of follow-up in the UK Biobank.

Authors:  Nicole Brenner; Alexander J Mentzer; Michael Hill; Rachael Almond; Naomi Allen; Michael Pawlita; Tim Waterboer
Journal:  EBioMedicine       Date:  2020-11-25       Impact factor: 8.143
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.